{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029711","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2025-12-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.078228+00:00","generated_at":"2026-05-16T11:56:50.068318+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Imunon raises $7.0M in registered direct offering of common stock and warrants","bullets":["Gross proceeds ~$7.0M from 1,939,114 shares/pre-funded warrants plus warrants at $3.61/unit.","Warrants exercisable at $3.482/share for 5 years; pre-funded warrants at $0.0001, no expiration.","Offering priced at-the-market under Nasdaq rules; expected to close December 31, 2025.","Net proceeds for general corporate purposes including R&D, capex, and working capital.","Maxim Group LLC is lead placement agent; Brookline Capital Markets is co-placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029711","json":"https://secwatch.observer/filing/0001493152-25-029711.json","markdown":"https://secwatch.observer/filing/0001493152-25-029711.md","text":"https://secwatch.observer/filing/0001493152-25-029711.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/0001493152-25-029711-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:56:50.068318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1cb7aa4125afdecb60e725ee119605499d0408ce","claim":"Imunon, Inc. entered into Securities Purchase Agreement with a single healthcare-focused institutional investor valued at combined offering price of $3.61 per Share and Warrant (effective 2025-12-29).","evidence_excerpt":"On December 29, 2025, Imunon, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single healthcare-focused institutional investor (the “Purchaser”) for a registered direct offering","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/0001493152-25-029711-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a single healthcare-focused institutional investor"},{"label":"Value","value":"combined offering price of $3.61 per Share and Warrant"},{"label":"Effective","value":"2025-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}